Eric Masson
Impact in
- Physical and Theoretical Chemistry top 0.5%
- Crystallography and molecular interactions
- Spectroscopy top 1%
- Molecular Sensors and Ion Detection
Papers in
-
- Supramolecular Chemistry and Complexes 28
- Oncology 37
- Colorectal Cancer Treatments and Studies 16
- Cancer Treatment and Pharmacology 10
- Co-authors
- Xiaoyong Lu (7 shared papers)Xiaoxi Ling (6 shared papers)Roymon Joseph (6 shared papers)Dirk Laurent (13 shared papers)Mary V. Relling (5 shared papers)William E. Evans (5 shared papers)John D. Schuetz (5 shared papers)Amit Roy (5 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Chemical Science (7 papers)Organic Letters (7 papers)The Journal of Clinical Pharmacology (6 papers)Drug Metabolism and Disposition (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Eric Masson
113 papers receiving 4.0k citations
Eric Masson's Hit Papers
Peers
Comparison fields: 5 of 133
- Physical and Theoretical Chemistry 652
- Spectroscopy 911
- Organic Chemistry 1.5k
- Hematology 394
- Oncology 868
Countries citing papers authored by Eric Masson
This map shows the geographic impact of Eric Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Masson more than expected).
Fields of papers citing papers by Eric Masson
This network shows the impact of papers produced by Eric Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Masson. The network helps show where Eric Masson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Masson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cucurbituril chemistry: a tale of supramolecular success Hit paper breakdown → | 2011 | 826 |
| 2 | 2006 | 264 | |
| 3 | 2005 | 178 | |
| 4 | 1996 | 167 | |
| 5 | 2013 | 145 | |
| 6 | 2005 | 129 | |
| 7 | 1999 | 88 | |
| 8 | 1997 | 86 | |
| 9 | 2014 | 86 | |
| 10 | 2017 | 83 | |
| 11 | 2011 | 69 | |
| 12 | 2006 | 65 | |
| 13 | 2014 | 65 | |
| 14 | 2010 | 62 | |
| 15 | 2006 | 60 | |
| 16 | Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma. | 2013 | 58 |
| 17 | 1997 | 57 | |
| 18 | 2013 | 54 | |
| 19 | 2009 | 52 | |
| 20 | 1998 | 48 |
About Eric Masson
Eric Masson is a scholar working on Organic Chemistry, Oncology, Molecular Biology, Physical and Theoretical Chemistry and Spectroscopy, having authored 118 papers that have together received 4.1k indexed citations. Recurring topics across this work include Supramolecular Chemistry and Complexes (28 papers), Crystallography and molecular interactions (18 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (10 papers), Pharmacogenetics and Drug Metabolism (9 papers), Molecular Sensors and Ion Detection (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Physical and Theoretical Chemistry (652 citations), Spectroscopy (911 citations), Organic Chemistry (1.5k citations), Hematology (394 citations) and Oncology (868 citations). Eric Masson has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Xiaoyong Lu, Xiaoxi Ling, Roymon Joseph, Dirk Laurent, Mary V. Relling, William E. Evans, John D. Schuetz, Amit Roy, Feng Yan and Manfred Schlosser. Their work appears in journals such as Journal of Clinical Oncology, Chemical Science, Organic Letters, The Journal of Clinical Pharmacology and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.